Alcohol is a historical part of British culture, and pubs remain central to communities across the country. Yet the same liquor is also responsible for filling A&E departments; absorbing police […]
Month: November 2014
The BMJ Today: Trade wars and naloxone
A free trade agreement between the European Union and the United States is designed to meet the interests of corporations rather than patients and must be stopped in its tracks, […]
Developing evidence based health policy in resource limited settings—lessons from Nepal
Few would argue against the benefits of evidence informed public health and health policies. However, efforts to inform health policy in resource limited settings face particularly daunting challenges—often specific to […]
The BMJ Today: What’s in a name?
Next time you sneak a peek at an author’s affiliations, ask yourself if they mattered to you. Do you pay more attention to a study from Harvard University in the […]
Richard Smith: No case for retracting Lancet’s Gaza letter
In 1973 about 280 000 scientific articles were published, but there were no retractions. When I became an editor in 1979, retractions were rare and of little interest to anybody. […]
David McCoy: The social, political, and ecological pathologies of the Ebola crisis cannot be ignored
The Ebola virus is finally receiving attention after years of being ignored as just another deadly disease in Africa. Yet it was only when the current outbreak got out of […]
Richard Lehman’s journal review—3 November 2014
NEJM 30 October 2014 Vol 371 1685 The treatment of childhood and adolescent cancer is territory that most of us don’t trespass on, but we’ll need to go there this week […]
The BMJ Today: Managers need to get ‘aht the flippin’ way
Many thanks to consultant psychiatrist Geoff Searle for providing the headline for today’s BMJ Today, shamelessly stolen from his weekend rapid response to the essay about “flipping healthcare,” published last […]